Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
September 14 2021
October 12th-14th & 19th-20th : Defymed at the Cell and Gene meeting on the MESA 2021 Defymed wi...
July 27 2021
September 5th-9th: Defymed at the conference of the European Society for Biomaterials Last year Defy...